- Home
- KOS vs BVS Comparison
KOS vs BVS Comparison
Compare KOS & BVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | KOS | BVS |
|---|---|---|
| Founded | 2003 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.6B | 617.1M |
| IPO Year | 2011 | 2016 |
Fundamental Metrics
Financial Performance| Metric | KOS | BVS |
|---|---|---|
| Price | $2.61 | $10.49 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 6 | 3 |
| Target Price | $1.91 | ★ $14.00 |
| AVG Volume (30 Days) | ★ 27.2M | 416.1K |
| Earning Date | 05-05-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 163.46 |
| EPS | N/A | ★ 0.33 |
| Revenue | ★ $1,288,352,000.00 | $568,087,000.00 |
| Revenue This Year | $27.19 | $7.52 |
| Revenue Next Year | N/A | $7.06 |
| P/E Ratio | ★ N/A | $29.97 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.84 | $5.81 |
| 52 Week High | $3.17 | $9.98 |
Technical Indicators
Market Signals| Indicator | KOS | BVS |
|---|---|---|
| Relative Strength Index (RSI) | 50.36 | 74.46 |
| Support Level | $1.64 | $8.43 |
| Resistance Level | $2.77 | N/A |
| Average True Range (ATR) | 0.20 | 0.36 |
| MACD | -0.07 | 0.11 |
| Stochastic Oscillator | 20.01 | 97.35 |
Price Performance
Historical ComparisonAbout KOS Kosmos Energy Ltd. (DE)
Kosmos Energy Ltd is a deepwater exploration and production company focused on meeting the world's growing demand for energy. It has diversified oil and gas production from assets offshore Ghana, Equatorial Guinea, Mauritania, Senegal and the Gulf of America. The Company had operations in four geographic reporting segments: Ghana, Equatorial Guinea, Mauritania/Senegal and the Gulf of America. The majority of revenue is derived from the Ghana segment.
About BVS Bioventus Inc.
Bioventus Inc is a medical device company focused on developing and commercializing products to relieve pain and address musculoskeletal conditions. The company operates through two reporting segments, U.S. and International, and its product portfolio is organized into three main business areas: Pain Treatments, Surgical Solutions, and Restorative Therapies, offering products such as hyaluronic acid injections for osteoarthritis, peripheral nerve stimulation devices, bone graft substitutes, and ultrasound-based fracture healing therapies.